Senores Pharmaceuticals Ltd IPO Synopsis

An Initial Public Offering is an opportunity for investors to take part in the growth of a company. It is always better to be in the first batch of investors. The shares offered by the company get listed on the stock exchanges and can be bought and sold by investors.

Senores Pharmaceuticals Ltd IPO
Registered Office: #.1101-1103 11th Flr South Twr,Ambali Bopal Road , Ahmedabad - 380054 , Gujarat , India. Phone : +91-79-2999 9857 Fax: Email : cs@senorespharma.com Website : www.senorespharma.com
Initial public offering of 14,887,723 equity shares of face value of (Rs)10 each ("Equity Shares") of Senores Pharmaceuticals Limited ("The Company" or the "Issuer") for cash at a price of (Rs)391 per equity share (including a share premium of (Rs)381 per equity share) ("Offer Price") aggregating to (Rs)582.11 crores (the "Offer"). The offer comprises of a fresh issue of 12,787,723 equity shares by the company aggregating to (Rs)500.00 crores (the "Fresh Issue") and an offer for sale of 2,100,000 equity shares (the "Offered Shares") aggregating to (Rs)82.11 crores (the "Offer for Sale"), comprising 250,000 equity shares aggregating to (Rs)9.78 crores by Swapnil Jatinbhai Shah, 550,000 equity shares aggregating to (Rs)21.51 crores by Ashokkumar Vijaysinh Barot, 300,000 equity shares aggregating to (Rs)11.73 crores by Sangeeta Mukur Barot and 1,000,000 equity shares aggregating to (Rs)39.10 crores by Prakash M Sanghvi (the "Selling Shareholders"). The offer shall constitute 32.33 % of the post-offer paid-up equity share capital of the company. The offer includes a reservation of 75,000 equity shares, aggregating to (Rs)2.93 crores constituting 0.16% of the post-offer paid-up equity share capital, for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The face value of the equity shares is (Rs)10 each and the offer price is 39.10 times the face value of the equity shares.

Issue		Money Payable On
Opens On	Closes On	Application	Allotment
20-Dec-24	24-Dec-24	(Rs)391.00-0.00	(Rs)0.00-0.00
Minimum Application for shares in Nos :38 Further Multiples of :38

(Rs Cr)

Lead Managers to the Issue

Project Cost

457.81

Ambit Pvt Ltd

Project Financed through Current Offer

582.11

Post Issue Equity Share Capital

46.05

Issue Price

(Rs)391.00

Projects

Funding the capital expenditure requirements by investment in of one of your its subsidiary Havix,for setting up a mfg facility for the production of sterlie injection in its Atlanta Facility	Funding inorganic growth through acquisition and other strategic initiatives and general corporate purposes
Re-payment/pre-payment in full or in part of certain borrowings availed by the company and its subsidiary namely Havix Ratnatris and PSI	Investment in its subsidiary namely Havix for re-payment/pre-payment in full or in part of certain borrowings availd by the subsidiaries
Funding the working capital requirements of the company and its subsidiary namely SPI ad Ratnatris	Investment in its subsidiary namely SPI and Ratnatri to fund their working capital requirements

Promoted By
Swapnil Jatinbhai
Ashokkumar Vijaysingh Barot
Anar Swapnil Shah

Listing At
BSE
NSE

Registrar to the Issue

MUFG Intime India Pvt Ltd